Cala kIQ (device for the treatment of neurological disorders)

2023: Device Announcement

On June 14, 2023, Cala announced the entry into the market of Cala kIQ wearables providing therapy for neurological disorders. The manufacturer claims high efficiency of its products.

Cala is also developing a Cala Trio device for transcutaneous afferent pattern stimulation (TAPS). It is designed to treat tremor, and its kIQ system provides therapy to relieve hand tremor in people with essential tremor and Parkinson's disease.

Cala kIQ (device for the treatment of neurological disorders)

Cala kIQ provides TAPS therapy supported by large clinical studies and real-world data. The device provides on-demand home therapy for ease of use and management of hand tremors. According to representatives of Cala, this type of tremor occurs when the patient arises at rest, active, under severe stress.

At Cala, we have always sought to increase patient access to TAPS therapy and accelerate innovation for indications beyond essential tremor! Current research suggests that tremors can seriously affect patients' mental health and daily activities. There is a real need for patients suffering from hand tremors to have a safe option to treat their symptoms, said Cala CEO Rene Ryan.

The conditions have historically been treated with drugs or even surgery, according to Cala. Cala kIQ offers a non-invasive, non-pharmacological solution with minimal side effects. The system measures each patient's unique tremor physiology and individually matches the stimulation regimen to relieve tremor. According to the developers, the system was created for ease of use by patients and medical professionals. On-demand therapy is provided with a wrist-worn device. The Cala kIQ system offers online data information through a patient portal www.MyCala.com. This allows patients to see the outcomes of therapy sessions over time and share them with physicians to adjust treatment plans.^[1]

Notes